Dyne Therapeutics Earnings
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.88
Dyne Therapeutics earnings summary
Dyne Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.88. In its most recent report on Jul 29, 2026 (Q2 2026), DYN posted EPS of $-1.08. Across the last 16 reports, DYN shares moved an average of 6.1% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
DYN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $-1.08 | — | +4.2% |
| May 11, 2026 | — | $-0.73 | — | +0.5% |
| Mar 2, 2026 | — | $-0.69 | — | +20.6% |
| Nov 5, 2025 | — | $-0.76 | — | +2.3% |
| Jul 28, 2025 | — | $-0.97 | — | +11.0% |
| May 8, 2025 | — | $-1.05 | — | +3.7% |
| Feb 27, 2025 | — | $-0.90 | — | -8.9% |
| Nov 12, 2024 | — | $-0.96 | — | +4.6% |
| Aug 12, 2024 | — | $-0.70 | — | +2.5% |
| May 2, 2024 | — | $-0.81 | — | -0.3% |
| Mar 5, 2024 | — | $-1.10 | — | +11.2% |
| Oct 30, 2023 | — | $-0.99 | — | +5.7% |
| Aug 3, 2023 | — | $-1.08 | — | -4.8% |
| May 11, 2023 | — | $-0.78 | — | +2.0% |
| Mar 2, 2023 | — | $-0.73 | — | -12.7% |
| Nov 3, 2022 | — | $-0.80 | — | -2.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.